BioPlus Acquisition Corp.
BIOS · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $6,109 | $0 | $1,253 | $1,213 |
| - Cash | $0 | $1 | $15 | $40 |
| + Debt | $5 | $5 | $505 | $481 |
| Enterprise Value | $6,114 | $4 | $1,744 | $1,654 |
| Revenue | $0 | $0 | $709 | $817 |
| % Growth | – | -100% | -13.3% | – |
| Gross Profit | -$1 | $0 | $243 | $269 |
| % Margin | – | – | 34.3% | 33% |
| EBITDA | -$1 | $0 | -$85 | -$25 |
| % Margin | – | – | -12% | -3.1% |
| Net Income | $5 | -$0 | -$52 | -$131 |
| % Margin | – | – | -7.3% | -16% |
| EPS Diluted | 0.2 | -0.022 | -0.4 | -1.06 |
| % Growth | 1,000.9% | 94.5% | 62.3% | – |
| Operating Cash Flow | -$1 | -$0 | -$20 | -$1 |
| Capital Expenditures | $0 | $0 | -$14 | -$9 |
| Free Cash Flow | -$1 | -$0 | -$34 | -$9 |